ArticleDiscover oncology2025
Prognostic impact of primary tumor resection and nomogram development for survival prediction in colonic neuroendocrine carcinoma patients with liver metastasis: a SEER database-based study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study aimed to investigate the prognostic impact of primary tumor resection in colonic neuroendocrine carcinoma (NECs) patients with liver metastasis, compare survival outcomes between left- and right-sided tumors, and develop a nomogram for predicting overall survival (OS) in this population.
methodsData from 449 colonic NECs patients with liver metastasis (2010-2021) were extracted from the SEER database. Patients were stratified by primary tumor location (left vs. right colon) and surgical resection status. Propensity score matching (PSM) was applied to balance the groups and subsequently investigate survival differences between them. Survival differences were analyzed using Kaplan-Meier curves and Cox regression. A nomogram integrating independent prognostic factors was developed using LASSO regression and validated for 6-, 12-, and 24-month OS prediction. Model performance was assessed via ROC curves, calibration plots, and decision curve analysis (DCA).
resultsRight-sided colonic NECs predominated (85.1%, n = 382) and exhibited better OS than left-sided tumors (before PSM: 7.0 m vs. 6.0 m, p = 0.038; after PSM: 8.0 m vs. 6.0 m, p = 0.031). Primary tumor resection independently improved survival in both left colon (9.0 m vs. 5.0 m for no surgery, p = 0.012) and right colon (9.0 m vs. 6.0 m for no surgery, p < 0.001) groups. The nomogram incorporated age, tumor size, and resection status, demonstrating moderate-to-strong predictive accuracy (AUC: 0.623-0.755 in training cohort; 0.691-0.760 in validation cohort). Calibration curves and DCA confirmed clinical utility.
conclusionRight-sided colonic NECs with liver metastasis have superior survival compared to left-sided tumors. Primary tumor resection is associated with prolonged OS, regardless of tumor location. The validated nomogram provides a practical tool for individualized prognosis prediction, supporting clinical decision-making in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.